Cargando…
Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (M(pro)) and Papain-like Protease (PL(pro))
[Image: see text] The SARS-CoV-2 pandemic has prompted global efforts to develop therapeutics. The main protease of SARS-CoV-2 (M(pro)) and the papain-like protease (PL(pro)) are essential for viral replication and are key targets for therapeutic development. In this work, we investigate the mechani...
Autores principales: | Omage, Folorunsho Bright, Madabeni, Andrea, Tucci, Amanda Resende, Nogara, Pablo Andrei, Bortoli, Marco, Rosa, Alice dos Santos, Neuza dos Santos Ferreira, Vivian, Teixeira Rocha, João Batista, Miranda, Milene Dias, Orian, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091420/ https://www.ncbi.nlm.nih.gov/pubmed/36952618 http://dx.doi.org/10.1021/acs.jcim.3c00168 |
Ejemplares similares
-
Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PL(pro): insights from computational chemistry studies
por: Nogara, Pablo Andrei, et al.
Publicado: (2022) -
MERS‐CoV papain-like protease (PL(pro)): expression, purification, and spectroscopic/thermodynamic characterization
por: Malik, Ajamaluddin, et al.
Publicado: (2017) -
Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
por: Kouznetsova, Valentina L., et al.
Publicado: (2020) -
In silico studies of M(pro) and PL(pro) from SARS-CoV-2 and a new class of cephalosporin drugs containing 1,2,4-thiadiazole
por: Delgado, Cássia Pereira, et al.
Publicado: (2022) -
Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines
por: Wildner, Guilherme, et al.
Publicado: (2023)